KRAS and hematologic disorder: Compared with iPSC-based modeling of hematologic malignancies that typically contain multiple mutated oncogenes [33, 41, 42], our RALD-iPSCs acted as an invaluable tool to investigate the considerable effect of KRAS (G13C) on cellular functions within an isogenic HPC pair.